Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.25.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Current Assets:    
Cash $ 3,314 $ 2,085
Accounts receivable, net as of allowances of $535 at December 31, 2024 and $3,287 as of March 31, 2024 11,426 6,552
Inventories 19,413 20,642
Prepaid expenses and other current assets 3,805 5,449
Total current assets 37,958 34,728
Property, plant, equipment and rental assets, net 21,058 25,854
Finance lease right-of-use assets 3,938 4,391
Operating lease right-of-use assets 9,321 12,279
Non-current portion of inventories 3,295 3,917
Other assets 2,791 3,037
Total assets 78,361 84,206
Current Liabilities:    
Accounts payable and accrued expenses 17,603 18,212
Accrued salaries and wages 1,053 1,220
Accrued warranty reserve 1,080 1,437
Deferred revenue, current 15,332 11,183
Finance lease liability, current 595 964
Operating lease liability, current 3,775 4,041
Factory protection plan liability 6,298 7,259
Exit new money notes, net of discount, current 7,845 28,911
Total current liabilities 53,581 73,227
Deferred revenue, non-current 609 675
Finance lease liability, non-current 1,933 2,300
Operating lease liability, non-current 5,806 8,527
Exit new money notes, net of discount, non-current 23,851  
Other non-current liabilities 264 264
Total liabilities 86,044 84,993
Commitments and contingencies (Note 13)
Temporary equity:    
Redeemable noncontrolling interests 13,859 13,859
Stockholders' deficiency:    
Preferred stock, $.001 par value; 1,000,000 shares authorized, and none issued
Additional paid-in capital 955,313 955,145
Accumulated deficit (976,874) (969,810)
Total stockholders' deficiency (21,542) (14,646)
Total liabilities, temporary equity and stockholders' deficiency 78,361 84,206
Voting Common Stock    
Stockholders' deficiency:    
Common stock 18 18
Non-voting common stock    
Stockholders' deficiency:    
Common stock $ 1 $ 1